[1]
M. Emmamally, “Secretory versus non-secretory hepatocellular carcinoma: associations of serum AFP, CEA and CA19-9 levels with clinical presentation, metastatic patterns, and survival”, J Circ Biomark, vol. 15, no. 1, pp. 8–14, Jan. 2026.